Passion. imagination. Collaboration. 

Pingping Hou, PhD

Principal Investigator

Assistant Professor

Center for Cell Signaling

Department of Microbiology, Biochemistry and Molecular Genetics

Member, Rutgers Cancer Institute of New Jersey

Associate Member, RBHS Institute for Infectious and Inflammatory Diseases

Rutgers RBHS-NJMS Cancer Center, Newark, NJ


B.S., Molecular Biology, China Agricultural University, Beijing, China, 2007

Ph.D., Cell Biology, Peking University, Beijing, China, 2014

Postdoctoral fellow, Cancer Biology, MD Anderson Cancer Center, Houston, TX, US, 2021


New Investigator Award from Rutgers CINJ, 2023

Lustgarten Foundation-AACR Pancreatic Cancer Career Development Award, 2022

Thomas H. and Mayme P. Scott Fellowship in Cancer Research, 2021

NIH-NCI K22 Career Transition Award, 2020

Harold C. and Mary L. Dailey Endowment Fellowship, 2020

AACR Scholar-in-Training Award, 2018

Meet the team

Daiyong Deng, phd

Research Associate (since 2021/11)

Dr. Deng earned his Ph.D. degree at South China Botanical Garden, Chinese Academy of Sciences in 2010. He is an expert in microbial engineering, and has established a solid research background in multiple biological disciplines including microbiology, genetics, molecular biology and biochemistry during his postdoc training. He has 5 first-author publications in the past 5 years and he is the co-inventor of 4 patents and the co-author of over 30 papers.

In Hou lab, Dr. Deng helps with lab management and dissects the role of genetic alternations in regulating KRAS targeted therapy resistance.

Nader Mahmoudzadeh, PHD

Postdoctoral Fellow (since 2023/03)

Nader was born in Tehran, Iran. He earned his PhD from Indiana University in 2022. While at Indiana he studied the role of a metabolite called L-2-hydroxyglutarate in the hypoxia response in Drosophila melanogaster.

In Hou lab, Dr. Mahmoudzadeh develops novel CAR macrophage therapeutics for pancreatic cancer treatment.

Habeebunnisa Begum, PHD

Postdoctoral Fellow (since 2023/05)

Habeeb earned her Ph.D from CSIR-Indian Institute of Chemical Technology. Her graduate work focused on understanding the role of apoptosis and autophagy in regulating cancer cell viability and determining the therapeutic potential of dual induction of apoptosis and autophagy in pancreatic cancer.

In Hou lab, Dr. Begum develops novel immunotherapies to treat pancreatic cancer.

rim ouni, PHD

Postdoctoral Fellow (since 2023/12)

Rim earned her PhD in immunology from University of Carthage in Tunisia in 2020. After that, she moved to The University of Texas MD Anderson Cancer Center at the department of Immunology, where she studied the immune landscape of anaplastic thyroid cancer.

In Hou lab, Dr. Ouni explores the intercellular crosstalk that regulates tumor responses to KRAS targeted therapy in pancreatic cancer.


Jason Xiong: summer student (2022/06-2022/07)

Riya Patel: research volunteer (2022/01-2022/08)

Roma Agarwal: summer student (2022/07-2022/08)

Luis Garza: graduate student (2021/09-2022/09)

Yaritza Rodriguez Vazquez: masters student (2022/10-2022/12) graduated.

Kevin Herrera: masters student (2023/01-2023/08) graduated.